Dextran sulfate sodium enhances interleukin-1β release via activation of p38 MAPK and ERK1/2 pathways in murine peritoneal macrophages
- 1 July 2007
- journal article
- Published by Elsevier in Life Sciences
- Vol. 81 (5) , 362-371
- https://doi.org/10.1016/j.lfs.2007.05.022
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Role of extracellular signal‐regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic culturesJournal of Neurochemistry, 2004
- Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphismsMediators of Inflammation, 2004
- Mammalian MAP kinase signalling cascadesNature, 2001
- Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokinesClinical and Experimental Immunology, 1998
- Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel diseaseThe Journal of Pathology, 1998
- Depleted mucosal antioxidant defences in inflammatory bowel diseaseFree Radical Biology & Medicine, 1995
- Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient miceGastroenterology, 1994
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Gut, 1992
- Cytokines in Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1992
- Interleukin-1 in the pathogenesis of and protection from inflammatory bowel diseaseBiotherapy, 1989